Table 2.
Baseline characteristics of included studies (based on IgG assessment).
| Author | Publication year | Study area | Study group | No of cases | sample size | IgG cases | Sero-prevalence | Age range | Serologic test | Ref |
|---|---|---|---|---|---|---|---|---|---|---|
| Zemene E. | 2012 | Jimma town | Pregnant women | 168 | 201 | 163 | 97.0% | 17–35 | ELISA | [3] |
| Walle F. | 2013 | Bahir Dar | HIV/AIDS patients | 101 | 103 | 90 | 89.1% | NA | ELISA | [9] |
| Alem H. | 2013 | Addis Ababa Tikur Anbesa Hospital | HIV/AIDS patients | 141 | 150 | 141 | 100.0% | NA | ELISA | [10] |
| Hailu A. | 2014 | Ethiopia selected areas | Pregnant women | 256 | 293 | 247 | 96.5% | NA | ELISA | [11] |
| Endris M. | 2014 | University of Gondar Hospital | Pregnant women | 341 | 385 | 341 | 100.0% | NA | LAT | [6] |
| Hailu A. | 2014 | Ethiopia selected areas | HIV/AIDS patients | 178 | 190 | 172 | 96.6% | NA | ELISA | [11] |
| Abamecha F. | 2016 | Mizan Aman Hospital | Pregnant women | 198 | 232 | 191 | 96.5% | NA | ELISA | [7] |
| Jejaw A. | 2017 | Mizan Aman Hospital | HIV/AIDS patients | 261 | 270 | 255 | 97.7% | 18–49 | ELISA | [16] |
NA: not applicable.